These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27199554)

  • 1. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
    Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle.
    Munoz L; Ramsay EE; Manetsch M; Ge Q; Peifer C; Laufer S; Ammit AJ
    Eur J Pharmacol; 2010 Jun; 635(1-3):212-8. PubMed ID: 20226180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
    Higham A; Karur P; Jackson N; Cunoosamy DM; Jansson P; Singh D
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1279-1288. PubMed ID: 29719383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive Suppression of LPS-Induced IL-10 and TNF-α by Pre-treatment of Dexamethasone and SB203580 in a Murine Alveolar Macrophage Cell Line (MH-S).
    Meng A; Wang B; Zhang X; Qi N; Liu D; Wu J
    Inflammation; 2015; 38(3):1260-6. PubMed ID: 25563207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
    J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7.
    Kim JS; Kim KD; Na HS; Jeong SY; Park HR; Kim S; Chung J
    Mol Oral Microbiol; 2012 Jun; 27(3):149-59. PubMed ID: 22520385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.
    Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD
    Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.
    Khorasani N; Baker J; Johnson M; Chung KF; Bhavsar PK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():283-91. PubMed ID: 25678784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α.
    Pan YX; Chen KF; Lin YX; Wu W; Zhou XM; Zhang XS; Zhang X; Shi JX
    J Clin Neurosci; 2013 May; 20(5):726-30. PubMed ID: 23540891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model.
    Zhou WD; Yang HM; Wang Q; Su DY; Liu FA; Zhao M; Chen QH; Chen QX
    Hum Reprod; 2010 Dec; 25(12):3110-6. PubMed ID: 20956267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages.
    Li XN; Su J; Zhao L; Xiang JB; Wang W; Liu F; Li HY; Zhong JT; Bai X; Sun LK
    Int Immunopharmacol; 2013 Nov; 17(3):785-92. PubMed ID: 24070708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
    Feng YJ; Li YY; Lin XH; Li K; Cao MH
    World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A supercritical CO₂ extract from seabuckthorn leaves inhibits pro-inflammatory mediators via inhibition of mitogen activated protein kinase p38 and transcription factor nuclear factor-κB.
    Jayashankar B; Mishra KP; Kumar MS; Udayasankar K; Misra K; Ganju L; Singh SB
    Int Immunopharmacol; 2012 Aug; 13(4):461-7. PubMed ID: 22664145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model.
    Dong X; Liu Y; Du M; Wang Q; Yu CT; Fan X
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):77-84. PubMed ID: 16723252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Tokuda H; Kanno Y; Ishisaki A; Takenaka M; Harada A; Kozawa O
    J Cell Biochem; 2004 Apr; 91(5):1053-61. PubMed ID: 15034939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
    Higham A; Lea S; Ray D; Singh D
    J Immunol Methods; 2014 Mar; 405(100):144-53. PubMed ID: 24530567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway.
    Liu S; Feng G; Wang GL; Liu GJ
    Eur J Pharmacol; 2008 Apr; 584(1):159-65. PubMed ID: 18328478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients.
    Singh D; Smyth L; Borrill Z; Sweeney L; Tal-Singer R
    J Clin Pharmacol; 2010 Jan; 50(1):94-100. PubMed ID: 19880675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes.
    Kong L; Liu J; Wang J; Luo Q; Zhang H; Liu B; Xu F; Pang Q; Liu Y; Dong J
    Int Immunopharmacol; 2015 Dec; 29(2):401-407. PubMed ID: 26507164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.